Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Costabel

Showing results (171-180 of 200) with videos related to

Pageof 20
Sort By:
American Journal of Respiratory and Critical Care Medicine|July 15, 2006
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvementRobert P Baughman, Marjolein Drent, Mani Kavuru, et al.
The European Respiratory Journal|January 24, 2012
The European Respiratory Society spirometry tent: a unique form of screening for airway obstructionSara Maio, Duane L Sherrill, William MacNee, et al.
The Lancet. Respiratory Medicine|October 3, 2019
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trialLuca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, et al.
The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Chest|July 12, 2016
A Global Survey on Whole Lung Lavage in Pulmonary Alveolar ProteinosisIlaria Campo, Maurizio Luisetti, Matthias Griese, et al.
The European Respiratory Journal|November 3, 2022
GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trialIrina R Strambu, Christian A Seemayer, Liesbeth M-C A Fagard, et al.
Respiration; International Review of Thoracic Diseases|January 24, 2021
S2K Guideline for Diagnosis of Idiopathic Pulmonary FibrosisJürgen Behr, Andreas Günther, Francesco Bonella, et al.
The European Respiratory Journal|July 19, 2014
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosisMarc A Judson, Robert P Baughman, Ulrich Costabel, et al.
BMC Pulmonary Medicine|August 13, 2015
GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disordersMatthias Griese, Ralf Zarbock, Ulrich Costabel, et al.
Respiratory Research|July 30, 2018
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosisAndreas Guenther, Ekaterina Krauss, Silke Tello, et al.
Pageof 20

Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
American Journal of Respiratory and Critical Care Medicine|July 15, 2006
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvementRobert P Baughman, Marjolein Drent, Mani Kavuru, et al.
The European Respiratory Journal|January 24, 2012
The European Respiratory Society spirometry tent: a unique form of screening for airway obstructionSara Maio, Duane L Sherrill, William MacNee, et al.
The Lancet. Respiratory Medicine|October 3, 2019
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trialLuca Richeldi, Evans R Fernández Pérez, Ulrich Costabel, et al.
The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Chest|July 12, 2016
A Global Survey on Whole Lung Lavage in Pulmonary Alveolar ProteinosisIlaria Campo, Maurizio Luisetti, Matthias Griese, et al.
The European Respiratory Journal|November 3, 2022
GLPG1205 for idiopathic pulmonary fibrosis: a phase 2 randomised placebo-controlled trialIrina R Strambu, Christian A Seemayer, Liesbeth M-C A Fagard, et al.
Respiration; International Review of Thoracic Diseases|January 24, 2021
S2K Guideline for Diagnosis of Idiopathic Pulmonary FibrosisJürgen Behr, Andreas Günther, Francesco Bonella, et al.
The European Respiratory Journal|July 19, 2014
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosisMarc A Judson, Robert P Baughman, Ulrich Costabel, et al.
BMC Pulmonary Medicine|August 13, 2015
GATA2 deficiency in children and adults with severe pulmonary alveolar proteinosis and hematologic disordersMatthias Griese, Ralf Zarbock, Ulrich Costabel, et al.
Respiratory Research|July 30, 2018
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosisAndreas Guenther, Ekaterina Krauss, Silke Tello, et al.
Pageof 20